Tokyo Smoke partners with Aphria to launch medical cannabis | 08 … – Markets Insider

TORONTO, ON–(Marketwired – August 10, 2017) – Tokyo Smoke breaks ground by introducing four medical cannabis strains in collaboration with Aphria Inc., one of Canada’s largest licensed producers of medical marijuana. This is the first time a Canadian consumer brand will partner with a Licensed Producer to launch medical cannabis in Canada, an inaugural event for the lifestyle brand, as well as the Canadian marketplace. Grown and distributed by Aphria under the ACMPR (Access to Cannabis for Medical Purposes Regulations), the cannabis strains will be available to patients with a valid medical prescription from August 24, 2017.

The four strains will launch as a part of a kit ($250), featuring unique Tokyo Smoke packaging, five grams of each strain along with custom crafted black glass jars and special welcome accessories. They will be available to order through the Aphria website; more information can be found here.

In celebration of this Canadian release, a one-time version of the kit ($500) will be available through the Aphria site and will include a limited edition, co-branded Tokyo Smoke PAX 3. This is the

Read More Here...

This entry was posted in Vaporizer E-Cigarette Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Trackbacks are closed, but you can post a comment.